NCT06960915 · ACTIVE NOT RECRUITING

Efficacy of Virtual Reality Reminiscence Therapy in Nursing Home Residents With Alzheimer's Disease or Related Diseases

This trial tests whether virtual reality headsets showing familiar local landmarks and villages from the Somme region of France can ease behavioral symptoms and improve quality of life in nursing home residents with Alzheimer's or related diseases. It compares this to standard group reminiscence sessions. It is not a drug trial, and no phase applies.

You may qualify if

  • Residents of the long-term care facilities of the Amiens-Picardie University Hospital,
  • Residents with mild to moderate Alzheimer's disease or related diseases, i.e. with an MMSE ≥ 10,
  • Residents or their legal representative agreeing to participate in the study.

You're excluded if

  • Non-residents of the long-term care facilities of the Amiens-Picardie University Hospital,
  • Residents with an MMS \< 10,
  • Residents or their legal representative refusing to participate in the study,
  • Residents in terminal palliative care,
  • Residents with disruptive behavioral disorders.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-02-11

View full record on ClinicalTrials.gov

All APOE4 clinical trials